Abstract:Circulation. 2019;139:2190–2191. DOI: 10.1161/CIRCULATIONAHA.118.038328 2190 Chaofu Ke, PhD Yueping Shen, PhD To the Editor: We read with great interest the work by Abdullah et al,1 in which the authors examined the long-term association of low-density lipoprotein cholesterol (LDL-C) with cardiovascular disease mortality in a low 10-year risk cohort. According to the results, LDL-C≥160 mg/dL was correlated with increased cardiovascular disease mortality, thus supporting consideration of new LDL-C thresholds for lipid-lowering interventions in low-risk individuals. We appreciate the authors’ contribution to an inadequately studied field, but 1 important issue has not been fully addressed by the authors. In the article, hazard ratios of all-cause mortality were calculated for different categories of LDL-C. The results clearly showed that these attenuated hazard ratios were not significant or marginally significant in univariable Cox analyses. Most importantly, results of multivariable Cox analyses were not provided. As indicated in the baseline characteristics given in Table 1, many influential factors of all-cause mortality (eg, sex, age, hypertension, body mass index, and high-density lipoprotein cholesterol) were largely unbalanced between the reference group and the higher LDL-C groups. All of these factors are prone to result in higher all-cause mortalities in the higher LDL-C groups compared with the reference group. After adjustment of these potential confounders, the minimal positive associations of LDL-C with all-cause mortality might vanish or even be reversed. Although this article focused on cardiovascular disease mortality, the ultimate benefit of LDL-C lowering is not justified if elevated LDL-C did not contribute to increased all-cause mortality. This issue should be treated seriously because in a systematic review of 30 cohorts with 68 094 elderly people (≥60 years of age), an inverse association between LDL-C and all-cause mortality was seen in 16 cohorts representing 92% of subjects, and none of the other cohorts found a positive association between LDL-C and all-cause mortality.2 Moreover, statin treatment, the most widely used LDL-C lowering therapy, has been proven to account for a variety of adverse effects such as diabetes mellitus3 and myalgia.4 Therefore, more rigorous analyses and interpretations of the associations of LDL-C with non–cardiovascular disease mortality and all-cause mortality are essential before drawing conclusions about the clinical implications of LDL-C.

Letter by Ke and Shen Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol with Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results from the Cooper Center Longitudinal Study".

Lower Baseline LDL Cholesterol Affects All-cause Mortality in Patients with First Percutaneous Coronary Intervention.

Low LDL-C Levels Are Associated with Risk of Mortality in a Chinese Cohort Study

Association of Low‐Density Lipoprotein Cholesterol Levels with More Than 20‐year Risk of Cardiovascular and All‐Cause Mortality in the General Population

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

Association of Low-Density Lipoprotein-Cholesterol with All-Cause and Cause-Specific Mortality

Is LDL cholesterol associated with long-term mortality among primary prevention adults? A retrospective cohort study from a large healthcare system

Association and its population heterogeneities between low-density lipoprotein cholesterol and all-cause and cardiovascular mortality: A population-based cohort study

HDL-C, Longitudinal Change and Risk of Mortality in a Chinese Cohort Study.

[Association of High-Density Lipoprotein Cholesterol with Risk of Cardiovascular Disease Mortality].

Abstract 10198: Association Between Admission Low-Density Lipoprotein Cholesterol and In-Hospital Mortality Among Inpatients with Acute Myocardial Infarction in China: Findings from CCC-ACS Project

Low-density Lipoprotein Cholesterol Was Inversely Associated with 3-Year All-Cause Mortality among Chinese Oldest Old: Data from the Chinese Longitudinal Healthy Longevity Survey

Low and High-Density Lipoprotein Cholesterol and 10-Year Mortality in Community-Dwelling Older Adults: the Shanghai Aging Study

Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China

Association of very Low-density Lipoprotein Cholesterol with All-cause and Cardiovascular Mortality in Peritoneal Dialysis.

Post-treatment level of LDL cholesterol and all-cause mortality in patients with atherosclerotic cardiovascular disease: evidence from real-world setting

U-Shaped Relationship of Non-HDL Cholesterol With All-Cause and Cardiovascular Mortality in Men Without Statin Therapy

The U-Shaped Association of Non-High-Density Lipoprotein Cholesterol Levels With All-Cause and Cardiovascular Mortality Among Patients With Hypertension

Investigating linear and nonlinear associations of LDL cholesterol with incident chronic kidney disease, atherosclerotic cardiovascular disease and all-cause mortality: A prospective and Mendelian randomization study

Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl

Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study